Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?

Al B Benson III*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)778-781
Number of pages4
JournalClinical Advances in Hematology and Oncology
Volume14
Issue number10
StatePublished - Oct 1 2016

Fingerprint

Adjuvant Chemoradiotherapy
Neoadjuvant Therapy
Chemoradiotherapy
Rectal Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

@article{8c651ba758b548cfae31f9f8734b13b7,
title = "Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?",
author = "{Benson III}, {Al B}",
year = "2016",
month = "10",
day = "1",
language = "English (US)",
volume = "14",
pages = "778--781",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "10",

}

Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy? / Benson III, Al B.

In: Clinical Advances in Hematology and Oncology, Vol. 14, No. 10, 01.10.2016, p. 778-781.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?

AU - Benson III, Al B

PY - 2016/10/1

Y1 - 2016/10/1

UR - http://www.scopus.com/inward/record.url?scp=84991584262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991584262&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 27930628

AN - SCOPUS:84991584262

VL - 14

SP - 778

EP - 781

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 10

ER -